Living with Tourette syndrome means carrying something invisible that the world constantly notices. The tic you cannot stop. The sound that escapes before you can catch it. The looks from strangers, the explanations at work, the exhaustion of fighting your own body all day long and then waking up and doing it again tomorrow.
If you have tried medications that did not work well enough, or worked but came with side effects that were their own kind of burden, you may have started wondering about medical marijuana. You are not alone in that. And in Pennsylvania, you have a legal path forward.
Does Tourette Syndrome Qualify for a PA MMJ Card?
Yes. Tourette syndrome is an explicitly listed qualifying condition under the Pennsylvania Medical Marijuana Act (Act 16 of 2016). It was added to the list in July 2019, when Pennsylvania’s Secretary of Health approved a recommendation from the Medical Marijuana Advisory Board based on growing evidence for cannabis in tic management.
You need a confirmed Tourette syndrome diagnosis from a licensed physician. There is no requirement that your tics be severe, that you have failed a specific number of medications, or that you have any particular co-occurring conditions. A diagnosis is the threshold.
Sources:
- Pennsylvania Department of Health – Medical Marijuana Qualifying Conditions
- PA Health Secretary Announcement – Tourette Syndrome Added July 2019
What Tourette Syndrome Actually Feels Like (Because the Medical Definition Misses Most of It)
Tourette syndrome is a neurological condition involving chronic motor tics (involuntary movements) and vocal tics (involuntary sounds or words). That is the clinical definition. But anyone who actually lives with TS knows that the definition barely scratches the surface.
What it actually feels like is a constant internal pressure, like an itch deep inside that builds and builds until you release it. That release is the tic. And suppressing it, even temporarily, takes real mental energy that leaves you drained in ways that are hard to explain to people who have never experienced it.
Tourette syndrome also rarely travels alone. Most people with TS also deal with one or more co-occurring conditions, ADHD, OCD, anxiety, depression, and sleep difficulties are common companions. Managing all of that, often on multiple medications with their own side effects, is genuinely exhausting.
The standard medications for TS, antipsychotics like haloperidol and aripiprazole, alpha-2 agonists like guanfacine and clonidine, help some people meaningfully. But the Tourette Association of America has found that 47% of adults and 44% of parents of children with Tourette syndrome do not feel their symptoms are adequately controlled. Nearly half. That is a lot of people still looking for something that works better.
Why Cannabis Makes Biological Sense for Tourette Syndrome
Here is the short version: tics in Tourette syndrome are believed to involve disrupted signalling in the basal ganglia, a brain region heavily involved in movement control. The endocannabinoid system, which cannabis acts on, is densely present in the basal ganglia. Cannabinoids, particularly THC, appear to modulate dopamine signalling in this region in ways that may tighten the “leaky filter” that lets tics through.
One researcher described it this way: Cannabis “tightens a leaky filter that stops the involuntary movements and vocalisations from getting out and being expressed.” That is not just a poetic metaphor, it reflects the actual neurological mechanism being studied.
CBD appears to work differently, with effects on anxiety and OCD symptoms that are particularly relevant for the co-occurring conditions that make TS harder to live with.
What the Research Shows
The NEJM Evidence Trial (2023) — The Strongest Study Yet
The most rigorous clinical trial of cannabis for Tourette syndrome to date was published in NEJM Evidence in 2023. Twenty-two adults with severe TS were enrolled in a double-blind, placebo-controlled crossover trial. Each participant received both an oral cannabis oil (containing equal parts THC and CBD at 5 mg/ml each) and a placebo — in random order — across two six-week treatment periods.
The result: tic scores on the Yale Global Tic Severity Scale dropped by an average of 8.9 points in the cannabis group versus 2.5 points in the placebo group, a statistically significant difference (p=0.008). Secondary outcomes including OCD symptoms and anxiety also improved under active treatment.
One participant in the trial, a 35-year-old who had lived with painful tics since childhood, described the experience this way: the oil reduced his tics by about 50 percent, and he was able to read a book for the first time in ten years. Some days, he said, he got home from work and realised he had not focused on his Tourette syndrome all day.
That is what “statistically significant” means in a real person’s life.
The most common side effects were cognitive difficulties, slowed thinking, memory lapses, poor concentration — in 8 of 22 participants. These are real effects to be aware of and to start low and titrate slowly to minimise.
- Source: NEJM Evidence – Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome (Mosley et al., 2023)
The Broader Evidence Picture
The 2024 systematic review and meta-analysis published in the European Journal of Clinical Pharmacology, the most comprehensive review of cannabis in TS to date, covering studies up to February 2024, concluded that cannabis-based medicine shows promising and potentially effective outcomes in reducing the severity of tics and premonitory urges. It found consistent signals across multiple study designs, while noting that larger placebo-controlled trials are still needed.
Earlier controlled trials of THC alone also found significant tic reduction versus placebo. By many epilepsy and movement disorder experts, THC is now recommended for treatment of TS in adult patients when first-line treatments have failed.
Longer-term real-world data from adult TS patients reports that sustained cannabis use reduces tic frequency by as much as 75%, while also improving mood, anxiety, and sleep, areas that matter enormously for quality of life in TS.
Sources:
- PubMed – Efficacy of Cannabis-Based Medicine in Tourette Syndrome: Systematic Review and Meta-Analysis (2024)
- PubMed – Treatment of Tourette Syndrome with Cannabinoids
- NORML – Cannabis Extracts Show Promise in Adolescents with Tourette Syndrome (2025)
It Is Not Just About the Tics
For many people with TS, the tics are not even the hardest part. It is the anxiety about when the next one will happen. The OCD thoughts that will not quiet down. The sleep that will not come because the tics keep interrupting it. The depression that builds from years of feeling different and misunderstood.
The NEJM Evidence trial found improvements in OCD symptoms and anxiety alongside tic reduction. CBD-dominant products specifically have a growing evidence base for anxiety relief that is directly relevant here. For PA patients whose primary burden is the co-occurring conditions as much as the tics themselves, cannabis offers something most TS medications do not, it addresses multiple aspects of the condition at once.
THC or CBD — Which One Is Right for Tourette Syndrome?
This is the most practical question, and the answer is different for Tourette syndrome than for many other conditions.
THC is the primary driver of tic reduction. The clinical trials that show the clearest benefit for motor and vocal tics used THC, either alone or in a balanced ratio with CBD. If tic control is your main goal, a balanced THC:CBD product or a mild THC-dominant product at low doses is where the evidence points.
CBD plays a supporting role, particularly for anxiety, OCD symptoms, and sleep. The combination of THC and CBD together, as used in the NEJM trial, appears to improve the side effect profile compared to THC alone. Many PA patients find the balanced 1:1 ratio (equal THC and CBD) offers the best combination of tic relief with manageable side effects.
Start very low with THC. The cognitive side effects seen in the NEJM trial, slowed thinking, memory issues are real and are more likely at higher doses. A starting dose of 2.5–5 mg THC equivalent is appropriate for most adults new to cannabis. Increase slowly over weeks, not days. The goal is the lowest dose that provides meaningful relief, not the highest dose you can tolerate.
PA Dispensary Product Guidance for Tourette Syndrome
Best Formats
Oral tinctures and oils are the most practical starting format for TS. They allow precise dose control, you can measure out 2.5 mg THC increments easily and sublingual absorption means you feel the effect within 15–45 minutes. The NEJM trial used an oral oil, which is the closest dispensary equivalent.
Capsules are good for daily maintenance once you have found your effective dose, since they are consistent and easy to take. Onset is slower (60–90 minutes) so they are better for ongoing management than acute relief.
Vaporised cannabis has a faster onset and can be useful for managing acute tic episodes or high-anxiety moments, but requires more caution around dose control. It is better suited to experienced users who already know their response to THC.
What to Ask For
When you visit a Pennsylvania dispensary, tell the pharmacist you have Tourette syndrome and that you are looking for a balanced THC:CBD product or a mild THC-dominant tincture with CBD present. Ask for something in a 1:1 or 2:1 (THC:CBD) ratio as a starting point. Mention if anxiety or OCD are significant concerns, they may lean toward a higher CBD ratio for you.
What to Avoid
Very high-THC products with no CBD are not the best starting point for TS. High doses of THC without CBD can increase anxiety, the opposite of what most TS patients need and worsen the cognitive side effects. The presence of CBD moderates THC’s psychoactive effects and improves tolerability.
A Note on Children and Adolescents
A significant number of Tourette syndrome patients are children and teenagers. Pennsylvania’s medical marijuana program does allow minors to participate, a parent or legal guardian registers as the caregiver and manages acquisition and administration on the child’s behalf.
However, the clinical trial evidence for cannabis in TS is primarily in adults. A 2025 pilot study in adolescents showed a positive signal, improvements in parent and self-reported tics and quality of life but the evidence base for pediatric use is still early-stage. For children and teenagers, a conversation with a paediatric neurologist or movement disorder specialist before starting cannabis is strongly recommended. The considerations around cognitive development and THC exposure in younger patients require careful, specialist input.
The adult evidence, however, is increasingly compelling and for adults who have tried the standard options without adequate relief, a PA MMJ card represents a well-supported, legal path to something that may genuinely help.
How to Get Your PA MMJ Card for Tourette Syndrome
Step 1 — Gather your diagnosis documentation.
You need documentation of your Tourette syndrome diagnosis, a neurologist’s records, a psychiatrist’s report, or any physician documentation confirming the diagnosis. You do not need extensive records, but the certifying physician needs to see that a qualifying condition is confirmed.
Step 2 — Book a telehealth certification appointment.
Find a PA DOH-registered medical marijuana certifying physician and book online. These appointments are done from home, take about 10–15 minutes, and are straightforward. Bring your diagnosis records and a list of any current medications. The physician submits your certification electronically to the Pennsylvania Department of Health.
Step 3 — Register with the PA MMJ Program.
After certification, register at the PA Medical Marijuana Program Patient Registry at patientportal.mmapinc.com. You will need your PA driver’s licence or state-issued ID and the $50 annual registration fee. Fee waivers are available if you are enrolled in Medicaid, PACE/PACENET, CHIP, SNAP, or WIC.
Step 4 — Visit a Pennsylvania dispensary.
Tell the pharmacist you have Tourette syndrome. Ask for a balanced THC:CBD oil or tincture. Start with the lowest available dose, take it consistently, and give it at least two to four weeks before evaluating whether to increase.
Other Qualifying Conditions
- Amyotrophic Lateral Sclerosis (ALS)
- Autism
- Cancer, including remission therapy
- Crohn’s Disease
- Damage to the nervous tissue of the central nervous system (brain-spinal cord) with objective neurological indication of intractable spasticity, and other associated neuropathies
- Epilepsy
- Glaucoma
- Positive status for Human Immunodeficiency Virus or Acquired Immune Deficiency Syndrome (HIV/AIDS)
- Huntington’s Disease
- Inflammatory Bowel Disease (IBD)
- Intractable Seizures
- Chronic Hepatitis C
- Anxiety Disorder
- Multiple Sclerosis
- Neuropathies
- Parkinson’s Disease
- Post-traumatic Stress Disorder (PTSD)
- Severe chronic or intractable pain of neuropathic origin or severe chronic or intractable pain
- Sickle Cell Anemia
- Neurodegenerative diseases (i.e., Alzheimer’s Disease)
- Terminal illness
- Dyskinetic and spastic movement disorders
- Opioid use disorder for which conventional therapeutic interventions are contraindicated or ineffective, or for which adjunctive therapy is indicated in combination with primary therapeutic interventions
Frequently Asked Questions
Q: I was diagnosed with Tourette syndrome as a child but my main symptoms now are anxiety and OCD. Do I still qualify?
Q: Will cannabis completely stop my tics?
Q: I take guanfacine or clonidine for my tics. Can I use cannabis alongside them?
Q: I take antipsychotics (aripiprazole, haloperidol) for TS. Any concerns?
Q: My doctor says cannabis has not been proven for Tourette syndrome. Are they right?
Pennsylvania Support Resources for Tourette Syndrome
Tourette Association of America — tourette.org The national authority on Tourette syndrome, with evidence-based information on all treatments including medical cannabis. Their published position on cannabis reflects the current state of the evidence honestly, recommended reading before your first dispensary visit.
TAA Pennsylvania Chapter — Find your local Pennsylvania chapter through tourette.org/find-a-chapter for local support groups, educational events, and peer connection.
Children and Adults with ADHD (CHADD) — chadd.org Relevant for TS patients managing co-occurring ADHD, one of the most common TS companions.
International OCD Foundation — iocdf.org Resources for the OCD symptoms that commonly co-occur with Tourette syndrome.
NOTE: Living with Tourette syndrome is harder than most people understand. The tics are visible. The internal experience is not. And for the people who have tried the standard options and are still looking, Pennsylvania’s medical marijuana program exists specifically to offer you another path. The evidence supports it. The law supports it. You deserve to explore it.